Alx Oncology Holdings (ALXO) — Long-term Investment Intensity
Alx Oncology Holdings (ALXO) has a Long-term Investment Intensity of 16.1% as of March 2026. Long-term investments of $28.78 Million represent 16.1% of total assets of $178.33 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Explore ALXO operating cash flow to assess how effectively this company generates cash.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Alx Oncology Holdings Long-term Investment Intensity (2022–2025)
This chart shows how Alx Oncology Holdings 's Long-term Investment Intensity has evolved across 4 annual periods from 2022 to 2025. As of March 2026, the intensity stands at 16.1%, reflecting long-term investments of $28.78 Million against total assets of $178.33 Million USD. Explore ALXO debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Alx Oncology Holdings (2022–2025)
The table below presents the year-by-year Long-term Investment Intensity for Alx Oncology Holdings from 2022 to 2025, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see ALXO stock market capitalisation.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 5.9% | $3.49 Million | $59.05 Million | ▲ +3.5 pp |
| 2024 | 2.4% | $3.52 Million | $147.78 Million | ▼ -12.2 pp |
| 2023 | 14.6% | $35.41 Million | $242.55 Million | ▲ +9.2 pp |
| 2022 | 5.4% | $16.70 Million | $306.49 Million | — |